VCIM
COCP icon

Velan Capital Investment Management’s Cocrystal Pharma COCP Stock Holding History

Velan Capital Investment Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$20.2K – 49
2024
Q4 		$20.2K Buy
+10,000
New +$20K 0.02% 44

Other funds holding COCP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Velan Capital Investment Management's COCP Position: Q1 2025 in Review

Velan Capital Investment Management sold out of Cocrystal Pharma (COCP) in Q1 2025, closing a stake of 10,000 shares — an estimated $20.2K sold.

Velan Capital Investment Management first reported a position in COCP in Q4 2024 and held it in 1 quarter. The position peaked at $20.2K in Q4 2024. 24 funds tracked by Wall St. Rank hold COCP as of Q1 2025.

  • Velan Capital Investment Management reported no remaining Cocrystal Pharma position as of Q1 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 10,000 Cocrystal Pharma shares in Q1 2025, an estimated $20.2K.
  • Velan Capital Investment Management first reported a position in Cocrystal Pharma in Q4 2024 and held it in 1 quarter.
  • Velan Capital Investment Management's Cocrystal Pharma position peaked at $20.2K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2025.

Based on Velan Capital Investment Management's 13F filing for Q1 2025, filed 15 May 2025.